Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 06, 2022

SELL
$97.41 - $116.74 $8,669 - $10,389
-89 Closed
0 $0
Q3 2021

Oct 08, 2021

BUY
$101.72 - $114.56 $9,053 - $10,195
89 New
89 $9,000
Q3 2018

Oct 11, 2018

SELL
$71.66 - $82.93 $13,328 - $15,424
-186 Closed
0 $0
Q2 2018

Jul 11, 2018

BUY
$58.93 - $74.24 $10,960 - $13,808
186 New
186 $13,000

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $84.7B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Vigilant Capital Management, LLC Portfolio

Follow Vigilant Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.